Pairing polysomnography results with machine learning algorithms can predict individual-level results on sleep latency tests, a new study finds.
New Help for Hypersomnias May Be on the Way
The prevalence of hypersomnia disorders — neurologic conditions characterized by bouts of sleepiness — is grossly underestimated. The shortage of effective therapies may be eased by several new clinical drug trials.
In Narcolepsy With Cataplexy, a New Form of Sodium Oxybate Promises Better Long-Term Safety
A new lower-sodium product is the latest in a wave of novel therapies with differing mechanisms of action that are improving quality of life for people with narcolepsy and its associated symptoms.
Solriamfetol Demonstrates Safety, Efficacy for Wakefulness in 1-Year Extension Trial
A long-term study has confirmed the durability of benefits and safety of a newly FDA-approved drug to treat excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy